𝔖 Bobbio Scriptorium

✦ LIBER ✦

Histological Evaluation of the Sheep’s Cervical Spine Segment 3/4 – A Histomorphological and Histomorphometrical Study

✍ Scribed by C. Koch; F. Kandziora; H. Huenigen; J. Plendl

Book ID: 110920887
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 891 KB
Volume: 37
Category: Article
ISSN: 0340-2096
DOI: 10.1111/j.1439-0264.2007.00829.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiological changes of the operated and

Radiological changes of the operated and adjacent segments following cervical arthroplasty after a minimum 24-month follow-up: comparison between the Bryan and Prodisc-C devices. Ryu K, Park C, Jun S, Huh H. J Neurosurg Spine 2010;13(3):299–307

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

The relationship between physical activi

The relationship between physical activity and low back pain outcomes: a systematic review of observational studies. Hendrick P, Milosavljevic S, Hale L, et al. Eur Spine J 2011;20(3):464–74. Epub 2010 Nov 4

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 57 KB

S3-4. New alarm point of transcranial el

S3-4. New alarm point of transcranial electrical stimulation motor evoked potentials for intraoperative spinal cord monitoring. A prospective multicenter study of the Spinal Cord Monitoring Working Group of the Japanese Society for Spine Surgery and Related Research (JSSR)

✍ Kobayashi, Sho; Matsuyama, Yukihiro; Sinomiya, Kenichi; Kawabata, Shigenori; And 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB